GlaxoSmithKline has opened a new £44 million aluminium salts facility in Montrose, Scotland. The plant will supply ingredients for around 400 million vaccines a year. Sterile aluminium salts enhance the body’s response to immunisation. The plant will supply to facilities in France, Belgium and Singapore that produce vaccines for tetanus and pneumonia.
The aluminium salts facility is expected to start in 2019 and add further 15 highly-skilled jobs to the firm’s existing workforce of 450.
“More than 20 million people a day rely on what we manufacture here at Montrose,” noted site director, Les Thomson.
GSK is expected to make a key ingredient for approx. 70% of the company’s vaccines portfolio in this plant.
{googleAdsense}
First minister Nicola Sturgeon who opened this facility also expressed her pleasure at the opening of the dedicated facility in Montrose, where GSK has been operating for more than 60 years.
“As well as creating very highly skilled jobs, the site will also be critical to helping to vaccinate millions worldwide against preventable diseases,” she added.
Responses
